Amp Capital Investors LTD Cytom X Therapeutics, Inc. Transaction History

Amp Capital Investors LTD

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 15, 2019	SELL	$9.5 - $19.16 $630,353 - $1.27 Million	-66,353 Closed	0 $0
Q3 2018 Nov 13, 2018	SELL	$18.04 - $26.41 $78,582 - $115,041	-4,356 Reduced 6.16%	66,353 $1.21 Million
Q2 2018 Aug 13, 2018	BUY	$21.38 - $29.68 $87,401 - $121,331	4,088 Added 6.14%	70,709 $1.62 Million
Q4 2017 Feb 14, 2018	BUY	$19.0 - $23.09 $497,477 - $604,565	26,183 Added 64.75%	66,621 $1.41 Million
Q3 2017 Nov 14, 2017	BUY	$13.53 - $18.17 $547,126 - $734,758	40,438	40,438 $735,000

49.4M

112K

8.3K

Ticker CTMX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,950,200
Market Cap $59.4M
Description
CytomX Therapeutics, Inc. operates as an oncology-focused biopharmaceutical company in the United States. The company develops antibody therapeutics based on its Probody technology platform for the treatment of cancer. The company's product candidates include CX-2009, an antibody drug conjugates (ADC) against CD166, which is in Phase II clinical...

Get notified when there are updates to the investment portfolio of Amp Capital Investors LTD, based on Form 13F filings with the SEC.

Stay updated on Amp Capital Investors LTD with notifications on news.